Riskpilot← Back to searchSign inGet full accessFredenholm Vårdkonsult AB
ABActiveOrg 5591864391Prästkragevägen 29General medical practice activities · NACE 8621Est. 20182 employees
Revenue 2025
SEK 253K
-9% vs 2024
EBITDA margin
63.9%
-24% vs 2024
Equity ratio
72.1%
Financial strength
Net profit 2025
SEK 130K
-26% vs 2024
| Revenue | SEK 253K | -9% |
| EBITDA | SEK 162K | -24% |
| Net profit | SEK 130K | -26% |
| Total assets | SEK 250K | -25% |
| Equity | SEK 180K | -27% |
| Employees | 2 | — |
Legal name
Fredenholm Vårdkonsult AB
Org number
5591864391
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 december 2018
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva verksamhet inom vårdsektorn, där grundarna kommer att erbjuda konsulttjänster inom respektive profession (läkare och sjuksköterska). Konsultarbetet kommer framförallt vara patientnära, på exempelvis sjukhus eller vårdcentraler. Konsultarbetet kan även komma att bedrivas inom den digitala vården. Kunderna kommer att vara privata eller offentliga vårdgivare inom Norden, i första hand Sverige
Address
Prästkragevägen 29
Email
sm.fredenholm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 358 | 191 | 335 | 277 | 253 |
| Staff expenses | — | −5 | −12 | −1 | −3 |
| EBITDA | 315 | 124 | 258 | 213 | 162 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 315 | 124 | 258 | 213 | 162 |
| Net financials | — | 0 | 3 | 8 | 2 |
| Profit before tax | 314 | 124 | 261 | 221 | 164 |
| Tax | −67 | −26 | −54 | −46 | −34 |
| Net profit | 247 | 99 | 208 | 176 | 130 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 457 | 206 | 358 | 331 | 250 |
| Equity | 346 | 155 | 263 | 248 | 180 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 111 | 51 | 95 | 83 | 70 |
| Total debt | 111 | 51 | 95 | 83 | 70 |
EBITDA margin
63.9%
This company
15.8%
Market median
+304% vs market
20212025
Equity ratio
72.1%
This company
38.2%
Market median
+89% vs market
20212025
Return on equity
72.2%
This company
18.4%
Market median
+292% vs market
20212025
Net profit margin
51.5%
This company
8.1%
Market median
+536% vs market
20212025
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
20212025
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fredenholm Vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofie Charlotte Fredenholm | Deputy Board Member | 0 companies |
| Marcus Lars Vittorio Fredenholm | Board of Directors | 0 companies |